DEWITT STETTEN, JR.

May 31, 1909-August 28, 1990

BY J. EDWIN SEEGMILLER

DEWITT STETTEN, JR., made significant contributions to science as a biochemist, as an unusually talented mentor in the training of young scientists, and as an inspiring and dedicated administrator of educational and research programs. Through his pioneering use of heavy isotopes as labels of various molecules, Stetten was one of the first investigators to obtain quantitative assessment of the dynamic relationship of interconversions between various molecules in intact biological systems. He extended these studies to include assessment of aberrations of relevant metabolic pathways in human diseases, including the first demonstration of an impaired synthesis of fatty acids in patients with diabetes and the causes of hyperuricemia in patients with gouty arthritis. In addition, Stetten's standards of integrity, his contagious excitement about science and life, his honesty, his warm personal concern for his friends, and his pervasive humor are well remembered by his many scientific associates and personal friends.

EARLY LIFE AND SCHOOLING

DeWitt Stetten, Jr., was born in New York City on May 31, 1909, to DeWitt Stetten, Sr., a prominent young surgeon,



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 333
--> DEWITT STETTEN, JR. May 31, 1909-August 28, 1990 BY J. EDWIN SEEGMILLER DEWITT STETTEN, JR., made significant contributions to science as a biochemist, as an unusually talented mentor in the training of young scientists, and as an inspiring and dedicated administrator of educational and research programs. Through his pioneering use of heavy isotopes as labels of various molecules, Stetten was one of the first investigators to obtain quantitative assessment of the dynamic relationship of interconversions between various molecules in intact biological systems. He extended these studies to include assessment of aberrations of relevant metabolic pathways in human diseases, including the first demonstration of an impaired synthesis of fatty acids in patients with diabetes and the causes of hyperuricemia in patients with gouty arthritis. In addition, Stetten's standards of integrity, his contagious excitement about science and life, his honesty, his warm personal concern for his friends, and his pervasive humor are well remembered by his many scientific associates and personal friends. EARLY LIFE AND SCHOOLING DeWitt Stetten, Jr., was born in New York City on May 31, 1909, to DeWitt Stetten, Sr., a prominent young surgeon,

OCR for page 333
--> and his wife, Magdalena Ernst Stetten. A German nursemaid caring for his older sister Margaret disliked the name DeWitt and so she gave Stetten the affectionate name of “Haensel" and Margaret the German contraction "Gretel." Thus, Stetten was known as "Hans" to all visitors, and the name persisted among family and friends throughout his life. As children, Stetten and his sister attended the Horace Mann School, an experimental school associated with Columbia University in New York City. While still a young boy in the Horace Mann Boy's School, Stetten's parents sought to help him overcome his excessive shyness by arranging for him to receive special instruction in performing magic from one of his teachers who had this as a hobby. He then entertained family and friends, as well as audiences on steamships during family vacation travels to and from Europe, as an amateur magician. The same teacher also taught a woodworking class at school—thus started two of Hans's lifelong hobbies. Another hobby was his construction at age 12 of a radio receiver using a galena crystal as a detector and a coil of wire wrapped around a wooden rolling pin as a tuner—all from instructions he found in the journal QST, the official publication of the American Radio Relay League. Stetten then progressively increased the performance of succeeding radios over the years as vacuum tubes became available. His resulting hobby of electronics was helpful to him later when he participated in the construction of two mass spectrometers used at different times in his research career. Stetten received an A.B. degree magna cum laude from Harvard College in 1930, along with membership in Phi Beta Kappa. Although he knew by this time that his first love was biochemistry, he was encouraged by his surgeon father as well as by his tutor and mentor at Harvard, Frank

OCR for page 333
--> Fremont-Smith, to attend medical school before embarking on a laboratory career. He therefore received his M.D. in 1934 from the College of Physicians and Surgeons of Columbia University. EARLY RESEARCH TRAINING After his internship and residency at Bellevue Hospital in New York City, Hans was convinced that, even with the best of medical care then available, the effectiveness of treatment was severely restricted by lack of knowledge of the normal human body and the changes induced in it by each disease process. Some years earlier Hans had spent part of a summer vacation in the laboratory of Dr. Rudolf Schoenheimer in Freiburg, Germany, and had become fascinated with Schoenheimer's brilliant mind and his approach to science. Since Dr. Schoenheimer had recently arrived on the faculty at Columbia University as a refugee from Germany, Stetten selected him as his mentor for his Ph.D. degree in biochemistry, which was awarded in 1940. For his dissertation, published with Schoenheimer, Stetten used the then newly developed technique of isotopic labeling with deuterium to follow the biological conversion of labeled palmitic acid to stearic and palmitoleic acid and the conversion of aliphatic alcohols to fatty acids in intact rats, published in two papers in the Journal of Biological Chemistry. He then continued his research by studying the origins of the extra fat in various types of fatty liver using 15N labeling to show the dynamic relationships of choline, ethanolamine, and related compounds, as well as the role of lipotrophic methyl groups in the synthesis of choline in rats. It was in 1941 that he married fellow graduate student Marjorie Roloff, known as Marney, and thus began both a scientific and a domestic partnership of over four decades, until her sudden death from a heart attack in 1983. They had four chil-

OCR for page 333
--> dren—Gail, Nancy, Mary, and George. A year later at Woods Hole, Massachusetts, where their two families had spent many summer vacations as friends, Stetten married Jane Lazarow, widow of Dr. Arnold Lazarow. ACCOMPLISHMENTS IN BIOMEDICAL RESEARCH Stetten was a superb teacher with a contagious enthusiasm for scientific research. From 1938 to 1947 he taught biochemistry and continued his research at Columbia University. One of his early students in research was Juan Salcedo, who on returning to his homeland eliminated the nutritional disease beri beri from Bataan province and subsequently held many high scientific offices in the Philippines. During a subsequent two years of teaching and research at Harvard University's Peter Bent Brigham Hospital, Stetten taught a course on the clinical aspects of biochemistry. One of his students was an undergraduate, Gordon Tompkins, who credited Stetten's course as being the decisive event contributing to his own decision to make a career in biochemistry and medicine, eventually becoming chief of the Laboratory of Molecular Biology at the National Institute of Arthritis and Metabolic Diseases, from which he became a professor of biochemistry and biophysics at the University of California, San Francisco. Stetten's research on gouty arthritis began in Boston with his use of heavy isotope labeling of uric acid to determine the pool size and turnover of uric acid in gout. In 1948 Stetten moved back to New York for his appointment as chief of the Division of Nutrition and Physiology of the Public Health Research Institute of the City of New York. He described this six-year period as one of the most productive times of his life. Among the bright young physicians attracted to his laboratory as a postdoctoral fellow was James Wyngaarden, later a director of the National Insti-

OCR for page 333
--> tutes of Health. Among the achievements of this general period was Stetten's demonstration of the marked expansion above normal of the miscible pool of uric acid in gouty humans and the role of overproduction of uric acid as the cause of hyperuricemia in at least a portion of gouty patients. For this and other major contributions of his laboratory during this period, Stetten was honored with election to the National Academy of Sciences. In 1954 Stetten was appointed associate director in charge of the intramural program of research at the National Institute of Arthritis and Metabolic Diseases of NIH. During his eight years in this position, he recruited a number of outstanding young scientists to the program, including Marshall W. Nirenberg, who became the intramural program's first Nobel laureate for his identification of the DNA code for specific amino acids. Stetten was also coauthor of the first two editions of Principles of Biochemistry with Abraham White, Phillip Handler, and Emil L. Smith, which was designed for graduate and medical students and widely adopted as the standard textbook of biochemistry. The authors spent summer vacations together in Woods Hole, Massachusetts, for the book's development and revisions. Stetten felt strongly the importance of formal teaching programs as an important symbiotic component of an optimal research environment. He therefore worked with other NIH researchers of like minds to aid in the establishment of the Foundation for Education in the Sciences, a nongovernmental teaching institution located adjacent to the NIH campus, and later served as its president. DEAN OF RUTGERS UNIVERSITY MEDICAL SCHOOL In 1962 Stetten left NIH to serve as the founding dean of the Rutgers University School of Medicine soon to be launched in Nutley, New Jersey. He used his considerable

OCR for page 333
--> skills as a negotiator to help establish a first-class medical school, complete with a strong program, excellent faculty, and a handsome medical sciences building. After much hard work on Stetten's part, the two-year medical school was up and running and the four-year medical school was ready to be launched; however, the state legislature decided to separate the medical school from the university in order to integrate it with the recently acquired Seton Hall Medical School. The merger was opposed by faculty, students, and administrators alike, but they were overruled by the legislature. When the merger took place, Stetten tendered his resignation. NIH ADMINISTRATION Stetten returned to Bethesda, Maryland, in 1970 to head the National Institute of General Medical Sciences. From 1974 to 1979 he was NIH's deputy director for science, guiding the intramural research activities of a vast number of researchers. During this time he also served as chairman of the recombinant DNA advisory committee. In response to concerns in the scientific community about potential dangers in biotechnology research, Stetten's committee drafted guidelines for scientists using the new techniques. In 1978 Stetten asked to be relieved of his duties as deputy director because of his deteriorating eyesight, caused by macular degeneration. Donald Fredrickson, then NIH director, appointed him senior scientific advisor to the director. From an office in Stone House, Stetten took up a number of new projects. He wrote a widely cited letter to the editor of the New England Journal of Medicine suggesting that ophthalmologists learn more about advising their visually handicapped patients on services available for the blind. Some years later the Library of Congress recognized Stetten's efforts on behalf of blind and low-vision people by asking

OCR for page 333
--> him to pose for a poster promoting its Talking Books program. At this time, in 1979, Stetten found the opportunity to do something about his long-held perception of the principal drawback facing each scientific director upon moving to the administration building: isolation from the research he hoped to foster. To counter this, Stetten established a Friday morning seminar series that became an honored forum for scientists to tell about their laboratory and clinical research activities. He also initiated the Museum of Medical Research, which now bears his name, during NIH's centennial observance. In the museum's collection is a gavel made by Stetten for NIH Director Robert Q. Marston and passed to his successors. An avid woodworker, Stetten made the gavel on his own lathe. For the head he used wood from the plane tree, found on the Aegean island of Cos and associated with Hippocrates, the father of medicine. The handle was made of all-American cherry wood. In another project, carried out in collaboration with William T. Carrigan, Stetten edited a book on the NIH intramural program, NIH: An Account of Research in Its Laboratories and Clinics. LEADERSHIP POSITIONS Always in demand as a leader, Stetten served as chairman of the Roche Institute of Molecular Biology's Scientific Advisory Committee from 1966 to 1970. In 1971 he was president of the Foundation for Advanced Education in the Sciences and from 1977 to 1979 headed the Society for Experimental Biology and Medicine. Long before his election to the National Academy of Sciences in 1974, Stetten served on many of the Academy's advisory committees. After his election, he served on the Academy's council, was a member at large for the Division of Medical Sciences, and served three terms on the Execu-

OCR for page 333
--> tive Committee. He also served two terms as a representative of the American Society of Biological Chemists. This long and event-filled list of accomplishments cannot convey Hans Stetten's humor, his care for and facility with language, and his refusal to be slowed down in his later years even by blindness. He was an amateur magician and a professional mediator, whose ability to guide and smooth the way brought him many positions of leadership during his sixty years in the service of science. HONORS AND DISTINCTIONS EDUCATION 1930 A.B., Harvard College 1934 M.D., Columbia University 1940 Ph.D. (Biochemistry), Columbia University SPECIAL TRAINING OR EXPERIENCE 1934-37 Intern, Resident, Bellevue Hospital, New York City 1947-49 Associate in medicine, Peter Bent Brigham Hospital, Boston 1952-53 Study Section on Nutrition and Metabolism, National Institutes of Health, Public Health Service, Bethesda, Md. EMPLOYMENT 1938-47 Assistant, Instructor, Assistant Professor, Department of Biochemistry, Columbia University 1947-48 Assistant Professor, Department of Biochemistry, Harvard University 1948-54  Chief, Division of Nutrition and Physiology, Public Health Research Institute of the City of New York 1954-62  Associate Director in Charge of Research and Chief, Section on Intermediary Metabolism, National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, Bethesda, Md.

OCR for page 333
--> 1962-70 Dean, Rutgers University School of Medicine, and Director, Medical Center 1970-74 Director, National Institute of General Medical Science, National Institutes of Health 1974-79 Deputy Director for Science, National Institutes of Health 1979-85 Senior Scientific Advisor, Office of the Director, National Institutes of Health MEMBERSHIPS American Academy of Arts and Sciences American Association for the Advancement of Science (fellow); Vice-President, 1962 National Academy of Sciences, 1974 American Society of Biological Chemists Harvey Society Phi Beta Kappa Alpha Omega Alpha Sigma Xi

OCR for page 333
--> SELECTED BIBLIOGRAPHY 1930 With F. Fremont-Smith. Studies in edema. J. Clin. Invest. 9:7. 1940 With R. Schoenheimer. The conversion of palmitic acid into stearic and palmitoleic acids in rats. J. Biol. Chem. 133:329. With R. Schoenheimer. The biological relations of the higher aliphatic alcohols to fatty acids. J. Biol. Chem. 133:347. 1941 Biological relationships of choline, ethanolamine and related compounds. J. Biol. Chem. 140:143. 1943 With G. F. Grail. The rates of replacement of depot and liver fatty acids in mice. J. Biol. Chem. 148:509. 1944 With G. E. Boxer. The role of thiamine in the synthesis of fatty acids from carbohydrate precursors. J. Biol. Chem. 153:607 With G. E. Boxer. Metabolic defects in alloxan diabetes. J. Biol. Chem. 156:271. 1945 With H. D. Keston and J. Salcedo. The effect of chain length of the dietary fatty acid upon the fatty liver of choline deficiency. J. Nutr. 29:167. With B. V. Klein. Effects of adrenalin and insulin upon glycogenesis in rats. J. Biol. Chem. 159:593. 1946 With M. R. Stetten. Biological conversion of inositol into glucose. J. Biol. Chem. 164:85. With M. R. Stetten. The distribution of deuterium in a sample of deuterio glucose excreted by a diabetic rabbit. J. Biol. Chem. 165:147.

OCR for page 333
--> 1947 The study of certain pathologic processes with the aid of isotopic hydrogen. N.Y. State J. Med. 47:1991. Carbohydrate metabolism. Annu. Rev. Biochem. 16:125. 1948 Studies in intermediary metabolism conducted with the aid of isotopic tracers. Bull. N.Y. Acad. Med. 24:300. 1949 With W. B. Patterson. A study of gastric HCl formation. Science 109:256 The alterations in metabolism incident to administration of insulin, adrenalin, and thyroid substances, studied with the aid of isotopes. Recent Prog. Horm. Res. 4:189. With J. D. Benedict and P. H. Forsham. The metabolism of uric acid in the normal and gouty human studied with the aid of isotopic uric acid. J. Biol. Chem. 181:183. 1950 The use of isotopes as metabolic tracers. Ann. Int. Med. 32:1. 1952 On the metabolic defect in gout. Bull. N.Y. Acad. Med. 28:664. 1953 With J. B. Wyngaarden. Uricolysis in normal man. J Biol. Chem. 203:9. With B. Bloom and M. R. Stetten. Evaluation of catabolic pathways of glucose in mammalian systems. J. Biol. Chem. 204:681 With T. F. Yu, L. R. Wasserman, J. D. Benedict, E. J. Bien, and A. B. Gutman. A simultaneous study of glycine N15 incorporation into uric acid and heme, and of Fe59 utilization, in a case of gout associated with polycythemia secondary to congenital heart disease. Am. J. Med. 15:845. 1954 With Y. J. Topper. Formation of "acetyl" from succinate by rabbit liver slices. J. Biol. Chem. 209:63.

OCR for page 333
--> 1955 With B. Bloom. The fraction of glucose catabolized via the glycolytic pathway. J. Biol. Chem. 212:555. With A. White, P. Handler, and E. L. Smith. Principles of Biochemistry. New York: McGraw-Hill. With J. E. Seegmiller and L. Laster. Incorporation of 4-amino-5-imidazolecarboxamide-4-C' 3 into uric acid in the normal human . J. Biol. Chem. 216:663. 1956 Medical research—A medical specialty? J. Chron. Dis. 3:651. 1957 With J. H. Talbott, J. E. Seegmiller, J. B. Wyngaarden, and L. Laster. The pathogenesis of gout—Letter to the editor. Metabolism 6:88. 1959 Gout. Perspect. Biol. Med. 2:185. With A. White, P. Handler, and E. Smith. Principles of Biochemistry, 2d ed. New York: McGraw-Hill. With J. Z. Hearon. Intellectual level measured by army classification battery and serum uric acid concentration. Science 129:1737. 1960 With M. R. Stetten. Glycogen metabolism. Physiol. Rev. 40:505 1963 With H. Katzen and F. Tietze. Further studies on the properties of hepatic glutathione-insulin transhydrogenase. J. Biol. Chem. 238:1005. 1964 Interface between basic medical sciences and their clinical branches. JAMA 189. 1968 Medical school curricular reform. Science 160:3834. 1971 Projected changes in medical school curriculum. Science 174:1303.

OCR for page 333
--> 1974 Targets. Science 185:209. 1977 Setting the priorities for biomedical research. Clin. Res. 25:228. 1978 Valedictory by the chairman of the NIH Recombinant DNA Molecule Program Advisory Committee (editorial). Gene 3:265. Amsterdam: Elsevier/North-Holland Biomedical Press. 1981 Coping with blindness. New Engl. J. Med. 305:458. 1982 The DNA disease. Nature 297:260.

OCR for page 333
-->